References
  1. Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al. Early Transmission Dynamics in Wuhan China, of Novel Coronavirus–Infected Pneumonia. N Engl J Med. 2020;382:1199–1207.
  2. World Health Organization. Novel coronavirus—China. https://www.who.int/csr/don/12-january-2020-novel-coronavirus-china/en/. Accessed January 12, 2020
  3. Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, et al. Extrapulmonary manifestations of COVID-19. Nat Med. 2020;26:1017-1032.
  4. Bansal M. Cardiovascular disease and COVID-19. Diabetes Metab Syndr. 2020;14:247-250.
  5. Hakmi H, Sohail A, Brathwaite C, Ray B, Abrol S. Cardiac tamponade in COVID-19 patients: Management and outcomes. J Card Surg. 2020;35:3183-3190.
  6. Asif T, Kassab K, Iskander F, Alyousef T. Acute Pericarditis and Cardiac Tamponade in a Patient with COVID-19: A Therapeutic Challenge. Eur J Case Rep Intern Med. 2020;7:001701.
  7. Ruan Q, Yang K, Wang W, Jiang L, Song J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 2020;46:846-848.
  8. Guo T, Fan Y, Chen M, Wu X, Zhang L, He T, et al. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA Cardiol 2020; 5: 811-818.
  9. Adler Y, Charron P, Imazio M, Badano L, Barón-Esquivias G, Bogaert J, et al. 2015 ESC Guidelines for the diagnosis and management of pericardial diseases: The Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC)Endorsed by: The European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2015;36:2921-2964.